Back to Journals » Journal of Experimental Pharmacology » Volume 13

Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab

Total article views   HTML views PDF downloads Totals
4,486 Dovepress* 4,020+ 445 4,465
PubMed Central* 466 153 619
Totals 4,486 598 5,084
*Since 31 May 2021
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 6 6

View citations on PubMed Central and Google Scholar